These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 35386045)
1. Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database. Valeiro C; Matos C; Scholl J; van Hunsel F Drug Saf; 2022 Jun; 45(6):639-650. PubMed ID: 35386045 [TBL] [Abstract][Full Text] [Related]
2. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting. Trenque T; Maura G; Herlem E; Vallet C; Sole E; Auriche P; Drame M Drug Saf; 2013 Jul; 36(7):515-9. PubMed ID: 23728950 [TBL] [Abstract][Full Text] [Related]
3. Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database. Gustafsson M; Matos C; Joaquim J; Scholl J; van Hunsel F Drug Saf; 2023 Nov; 46(11):1133-1148. PubMed ID: 37824028 [TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors. Ekhart C; van Hunsel F; Scholl J; de Vries S; van Puijenbroek E Drug Saf; 2018 Jul; 41(7):677-683. PubMed ID: 29484612 [TBL] [Abstract][Full Text] [Related]
5. Psychiatric adverse drug reactions in the paediatric population. Ekhart C; Vries T; Hunsel FV Arch Dis Child; 2020 Aug; 105(8):749-755. PubMed ID: 32060030 [TBL] [Abstract][Full Text] [Related]
6. [Does sexual dysfunction persist upon discontinuation of selective serotonin reuptake inhibitors?]. Ekhart GC; van Puijenbroek EP Tijdschr Psychiatr; 2014; 56(5):336-40. PubMed ID: 24838589 [TBL] [Abstract][Full Text] [Related]
7. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771 [TBL] [Abstract][Full Text] [Related]
8. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting. Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028 [TBL] [Abstract][Full Text] [Related]
9. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016. Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250 [TBL] [Abstract][Full Text] [Related]
10. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance. Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717 [TBL] [Abstract][Full Text] [Related]
11. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Aagaard L; Nielsen LH; Hansen EH Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778 [TBL] [Abstract][Full Text] [Related]
12. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands. Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243 [TBL] [Abstract][Full Text] [Related]
14. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese. Inácio P; Airaksinen M; Cavaco A Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069 [TBL] [Abstract][Full Text] [Related]
15. The temporal association between adverse drug reactions and antirheumatic drugs utilisation in Western Australia: a retrospective study from real-world data (1995-2015). Almutairi KB; Inderjeeth CA; Preen DB; Keen HI; Nossent JC Rheumatol Int; 2024 Jun; 44(6):1089-1099. PubMed ID: 38615313 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study. Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896 [TBL] [Abstract][Full Text] [Related]
17. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database. Castillon G; Salvo F; Moride Y Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742 [TBL] [Abstract][Full Text] [Related]
18. Paradoxical adverse drug reactions: descriptive analysis of French reports. Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024 [TBL] [Abstract][Full Text] [Related]
19. Patient Reporting in the EU: Analysis of EudraVigilance Data. Banovac M; Candore G; Slattery J; Houÿez F; Haerry D; Genov G; Arlett P Drug Saf; 2017 Jul; 40(7):629-645. PubMed ID: 28417320 [TBL] [Abstract][Full Text] [Related]
20. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA. Pariente A; Daveluy A; Laribière-Bénard A; Miremont-Salame G; Begaud B; Moore N Drug Saf; 2009; 32(5):441-7. PubMed ID: 19419238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]